Qbiotics aims for IPO ‘window of opportunity’
With Virgin shares holding nicely at cruising altitude, is now the right time for Brisbane-based private oncology drug developer Qbiotics to debut?
With Virgin shares holding nicely at cruising altitude, is now the right time for Brisbane-based private oncology drug developer Qbiotics to debut?
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
With markets shaky and super rules shifting, SMSFs turn to private credit for income and stability.
Geological modelling of gravity, magnetic and airborne electromagnetic data confirms five targets for initial drilling by TR2 in the West Arunta.
Green Technology Metals’ maiden rubidium resource adds a new dimension to the strategic value of its Seymour project in Ontario, Canada.
The ASX wobbled as Tesla stalled and Bapcor crashed, while Fortescue surged and Northern Star ditched its gold hedge.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
With 52 per cent of Australian crypto investors reporting a profit in 2025, tax time is top of mind. Binance answers common crypto tax questions.
Former RHC Australia CEO and EMVision’s newest board director Carmel Monaghan believes the company’s early stroke-detection tech has huge potential.
The ASX has fallen 0.31pc with 10 of 11 sectors lower. Healthcare lifted 1.04pc, posting solid gains despite market riptides.
GT1 has defined a maiden rubidium resource that enhances its large lithium resource and adds a new dimension to Seymour value calculations.
February saw Trump’s tariffs shake up the markets, with ASX tech taking a hit, led by WiseTech’s sharp drop.
The IoT boom is transforming industries, with Simble, EP&T, and X2M Connect leading the ASX in this space.
As China and the European Union engage in their 25th high-level summit in Beijing late this week, a delicate dance is unfolding.
Original URL: https://www.adelaidenow.com.au/business/stockhead/page/9